Bulletin
Investor Alert

New York Markets After Hours

Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

After Hours

/zigman2/quotes/206690250/composite

$

79.00

Change

+0.75 +0.96%

Volume

Volume 11,043

Sep 25, 2020, 4:49 p.m.

Real time quotes

/zigman2/quotes/206690250/composite

Today's close

$ 75.33

$ 78.25

Change

+2.92 +3.88%

Day low

Day high

$74.76

$78.50

Open
Open: 75.69

52 week low

52 week high

$23.81

$82.60

Open

Market cap

$15.93B

Average volume

2.31M

P/E ratio

31.98

Rev. per Employee

$1.21M

EPS

2.45

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/hznp

MarketWatch News on HZNP

  1. Horizon Therapeutics started at overweight with $110 stock price target at J.P. Morgan

    7:54 a.m. Sept. 9, 2020

    - Tomi Kilgore

  2. Horizon's stock jumps on FDA adcomm support for eye drug

    9:40 a.m. Dec. 16, 2019

    - Jaimy Lee

  3. Horizon Therapeutics halted for FDA advisory committee meeting on treatment for thyroid eye disease

    8:01 a.m. Dec. 13, 2019

    - Ciara Linnane

  4. Horizon Therapeutics shares halted premarket for news pending

    7:56 a.m. Dec. 13, 2019

    - Ciara Linnane

  5. Four stocks that are nearing key breakouts

    3:23 p.m. Oct. 16, 2019

    - Harry Boxer

  6. Horizon Therapeutics upgraded to outperform from market perform at BMO Capital

    1:41 p.m. Aug. 14, 2019

    - Tomi Kilgore

  7. Horizon Pharma stock up 7.8% premarket

    8:07 a.m. Feb. 28, 2019

    - Ciara Linnane

  8. Horizon Pharma announces positive results in late-stage trial of treatment for active thyroid eye disease

    8:07 a.m. Feb. 28, 2019

    - Ciara Linnane

  9. Horizon Pharma narrows loss, but sales decline

    8:27 a.m. Feb. 28, 2018

    - MarketWatch.com

  10. Horizon Pharma reiterated as buy at Goldman Sachs

    9:45 a.m. Jan. 24, 2018

    - Ciara Linnane

  11. Morning Movers: Tyson Jumps, Horizon Soars, Teva Tumbles

    8:43 a.m. Aug. 7, 2017

    - Barrons Blogs

  12. Horizon Pharma shares surge 19% premarket

    7:41 a.m. Aug. 7, 2017

    - Emma Court

  13. Horizon Pharma raises 2017 revenue guidance to $1.01 bln to $1.05 bln from $985 mln to $1.02 bln

    7:41 a.m. Aug. 7, 2017

    - Emma Court

  14. Horizon Pharma Q2 revenue $290 mln; FactSet consensus 237 mln

    7:39 a.m. Aug. 7, 2017

    - Emma Court

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/hznp

Other News on HZNP

  1. Gilead's Rheumatoid Arthritis Drug Gets Approval in Japan

    9:30 a.m. Today

    - Zacks.com

  2. BioMarin Initiates Gene Therapy Study for Phenylketonuria

    7:53 a.m. Today

    - Zacks.com

  3. Pfizer Seeks Xalkori's Label Expansion, Gets Priority Review

    10:22 a.m. Sept. 24, 2020

    - Zacks.com

  4. Genocea to Initiate a Phase I/II Oncology Study on GEN-011

    11:40 a.m. Sept. 23, 2020

    - Zacks.com

  5. Axsome Expedites Development Plan for Narcolepsy Candidate

    12:19 p.m. Sept. 22, 2020

    - Zacks.com

  6. Cue Biopharma (CUE) Catches Eye: Stock Jumps 5.2%

    8:36 a.m. Sept. 10, 2020

    - Zacks.com

  7. 6 of the Best Pharmaceutical Stocks to Buy Today

    1:54 p.m. Sept. 8, 2020

    - InvestorPlace.com

  8. How Has HZNP Performed 30 Days Post Earnings

    11:31 a.m. Sept. 4, 2020

    - Zacks.com

  9. Loading more headlines...
/news/pressrelease/company/us/hznp

Press Releases on HZNP

  1. PEGylated Protein Therapeutics Market Size to accrue $ 11600 million by 2025

    12:39 a.m. Sept. 23, 2020

    - Market Insight Reports

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.